NASDAQ · BCTX
BriaCell Therapeutics Corp.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for BCTX: Dec 10, 2026
BriaCell Therapeutics Corp. Common Shares is estimated to report earnings on 12/10/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-4.35.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks- RTTNews · Oct 23, 8:42 AM EDTBriaCell Announces Biomarker Findings In Metastatic Breast Cancer Study, Stock Up In Pre-Market(RTTNews) – On Friday, BriaCell Therapeutics Corp. (BCTX) announced clinical biomarker findings from a prospective pooled analysis of patients with metastatic breast cancer treated with immunotherapy.
- RTTNews · Jun 26, 6:06 AM EDTBriaCell Partners With Uneedle To Support Scalable Microneedle Delivery Of Bria-IMT(RTTNews) – BriaCell Therapeutics Corp. (BCTX), a clinical-stage biotechnology company developing novel immunotherapies for cancer, has entered into a Memorandum of Understanding with Uneedle, a Netherlands-based microneedle-based drug-delivery company, to support the continued u
- RTTNews · Jun 1, 1:46 AM EDTBriaCell Prices $4.7 Million Offering Of Shares; Stock Down(RTTNews) – BriaCell Therapeutics Corp. (BCTX), a clinical-stage immuno-oncology-focused biotechnology company, priced its public offering of 1.45 million shares at $3.25 per share.
- RTTNews · May 26, 8:22 AM EDTBriaCell Gains Sixth Position DSMB Recommendation For Phase 3 Breast Cancer Study(RTTNews) – BriaCell Therapeutics Corp. (BCTX) a clinical-stage biotechnology company developing novel immunotherapies, announced that the independent Data Safety Monitoring Board (DSMB) has issued its sixth consecutive positive recommendation for the company's pivotal Phase 3 Br
- RTTNews · Jan 14, 6:19 AM ESTBriaCell Plunges On Pricing Announcement Of $30Mln Public Offering(RTTNews) – BriaCell Therapeutics Corp. (BCTX, BCTXL), a clinical-stage biotechnology company, on Wednesday announced the pricing of a public offering of 5.367 million units at $5.59 per unit, for gross proceeds of approximately $30 million.
- RTTNews · Jan 13, 3:32 PM ESTBCTX Surges On Positive Clinical Response In Metastatic Cancer Immunotherapy Study(RTTNews) – BriaCell Therapeutics Corp. (BCTX) shares were trading at $10.61, up 39.06% or $2.98 higher, following news of a sustained complete resolution of a lung metastasis in a metastatic breast cancer patient treated with the company's Bria-OTS personalized immunotherapy in
- RTTNews · Jan 13, 9:08 AM ESTBriaCell Surge Above 50%; What's The Buzz?(RTTNews) – BriaCell Therapeutics Corp. (BCTX), a clinical-stage biotechnology company, on Tuesday reported durable and sustained complete resolution of a lung metastasis in a patient with metastatic breast cancer treated with its off-the-shelf immunotherapy candidate Bria-OTS.
- RTTNews · Jan 8, 10:12 PM ESTAfter-Hours Biotech Gainers: RVMD Soars On Merck Deal Talks Reports, SXTC, KALV, SGMT Rally(RTTNews) – Several biotechnology and pharmaceutical companies posted notable gains in Thursday's after-hours trading session, driven by corporate updates, clinical milestones, and acquisition speculation.
- Zacks · Oct 28, 4:01 AM EDTZacks.com featured highlights include Groupon, BriaCell Therapeutics and InnovAge HoldingGroupon, BriaCell Therapeutics, and InnovAge shine as Zacks' top November picks for powerful earnings acceleration potential.
- Zacks · Oct 27, 3:05 PM EDTTop 3 Earnings Acceleration Buys for NovemberGroupon, BriaCell Therapeutics and InnovAge stand out with accelerating earnings momentum as November's market optimism approaches.
- RTTNews · Oct 22, 8:39 AM EDTDSMB Issues Positive Review For BriaCell's Bria-IMT Phase 3 Study In Breast Cancer(RTTNews) – BriaCell Therapeutics Corp. (BCTX), a clinical-stage biotechnology company, on Wednesday announced that the independent Data Safety Monitoring Board (DSMB) has issued its fourth consecutive positive recommendation following review of safety data from Phase 3 study of
- RTTNews · Oct 21, 4:52 PM EDTBriaCell Rises On Phase 3 Expansion And MSK Collaboration(RTTNews) – BriaCell Therapeutics Corp. (BCTX) rose 4.16% to trade at $12.77, up $0.51, following news of a collaboration with Memorial Sloan Kettering Cancer Center's Therapeutics Accelerator and the expansion of its Phase 3 pivotal study (NCT06072612).
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for BriaCell Therapeutics Corp. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.